Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Lipid profile" is not a molecule, receptor, or therapeutic target. Instead, it refers to a group of laboratory tests that measure the levels of various lipids in the blood—primarily total cholesterol, LDL ("bad") cholesterol, HDL ("good") cholesterol, and triglycerides. These measurements are used as biomarkers to assess an individual's risk for cardiovascular diseases such as heart attack and stroke. The lipid profile itself does not represent a single molecular entity but rather serves as a clinical tool for risk stratification and monitoring response to therapy with lipid-lowering agents like statins, ezetimibe, fibrates, PCSK9 inhibitors, and others[1][3][5][6]. Note: If you are seeking information about specific molecular targets involved in lipid metabolism (such as "Low-density lipoprotein receptor" or "Proprotein convertase subtilisin/kexin type 9"), please specify the exact molecule or protein name.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid profile.